Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
The Prescription Monitoring Program (PMP) operated by the NM Board of Pharmacy, which collects data on every controlled substance prescription filled in New Mexico. New Mexico Medicaid in the Human Services Department, for data on methadone treatment paid by Medicaid, and for data on claims paid for naloxone prescriptions at pharmacies. Gabapentin isn’t classified as a controlled substance under federal law in the United States. But it is classified as a controlled substance in some states. Gabapentin is a prescription medication approved by the FDA for the treatment of neuropathic pain (postherpetic neuralgia) and seizure disorders. Why is gabapentin controlled in some states? Gabapentin is structurally and pharmacologically related to pregabalin (Lyrica, Lyrica CR), which is a Schedule V drug and controlled federally in all states. Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions. However, its increasing use has raised concerns about potential misuse and addiction. As a result, various states have begun to classify gabapentin as a controlled substance. Understanding the legal status of gabapentin across different jurisdictions is crucial A. It is unlawful for a person intentionally to possess a controlled substance unless the substance was obtained pursuant to a valid prescription or order of a practitioner while acting in the course of professional practice or except as otherwise authorized by the Controlled Substances Act. It is unlawful for a person intentionally to possess a controlled substance analog. B. A person who The Prescription Monitoring Program (PMP) operated by the NM Board of Pharmacy, which collects data on every controlled substance prescription filled in New Mexico. “Drug of concern” means a non-controlled dangerous drug that the Board has by rule determined to require dispenser PMP reporting of in the same manner as controlled substance prescription dispensing, when required reporting is expected to protect patients due to interaction of the drug of concern with controlled substances or other 2.1 Data Collection Overview The New Mexico Prescription Monitoring Program (PMP) accumulates Schedule II–V controlled substance and non-veterinary Gabapentin dispensing information into a restricted access online database in order to meet its mission to reduce the diversion of controlled substances while serving as a valuable tool for legitimate medical practice and patient care. Gabapentin closely resembles pregabalin, a schedule V drug under the Controlled Substances Act in its chemical structure and pharmacological activity. The chemical structure of gabapentin is derived from the addition of a lipophilic cyclohexyl group to the backbone of gamma-aminobutyric acid (GABA). The New Mexico Board of Pharmacy send out communication on April 6th that effective February 28, 2023 gabapentin prescriptions are now required to be reported to the New Mexico PMP. Gabapentin is not classified as a controlled substance. This rule change is available at 16.19.29 NMAC. "16.19.29 NMAC has been amended to require reporting of Gabapentin to the New Mexico PMP as a non-scheduled On April 6, 2023, the New Mexico Board of Pharmacy (NMBOP) sent out a communication to all prescribers and pharmacists. The communication stated that practitioners must report all dispensed gabapentin prescriptions to the New Mexico Prescription Monitoring Program (PMP) to facilitate evaluation of potential risk factors for respiratory depression. Gabapentin is not classified as a controlled This number is found on the medication bottle. The New Mexico Prescription Monitoring Program collects dispensed controlled substance information in schedules II-V, and gabapentin, as a non-scheduled “drug of concern.” All Dispensers shall report within one (1) business day of a prescription being filled. The Nursing Practice Act (NPA, Chapter 61, Article 3, NMSA) and the accompanying New Mexico Board of Nursing (NMBON) Rules and Regulations (16.12 NMAC) govern nursing practice in New Mexico. Nurses in New Mexico must practice within the parameters of the law and regulations. A significant aspect of the rules and regulations governing NP practice are laws, regulations and guidelines specific to The New Mexico Prescription Monitoring Program (PMP) is a web-based electronic database that aids in the reporting of dispensed controlled substance and gabapentin prescriptions. 16.19.29.2 SCOPE: All persons that dispense controlled substances and drugs of concern pursuant to prescriptions from practitioners and practitioners who dispense controlled substances and drug (s) of concern directly to a patient under their care. All persons authorized to receive disclosure of prescription monitoring program prescription information. Regulations relevant to Prescribing controlled substances In addition to following regulations when prescribing dangerous drugs, NPs must also follow additional regulations that govern controlled substances (CS), including opioids. The experience of New Mexico with a significant increase in numbers of overdose deaths from controlled substances lead to the 2012 passage of Senate Bill 215 Gabapentin is a controlled substance in states like Michigan and Kentucky, while others have mandated reporting rules. Learn about its risk for abuse here. Please note: Whenever the New Mexico Board of Pharmacy changes a rule, a period of time will pass before the rule is posted. This is because several things must happen: The rule must first be prepared by the board secretary. After the rule is prepared, the format must be approved in Santa Fe. When approved, the rule is submitted to be published in the New Mexico Register. The Register is 16.19.20.6OBJECTIVE: The objective of Part 20 of Chapter 19 is to protect the public health and welfare of the citizens of New Mexico by controlling and monitoring access to controlled substances and to give notice of the board’s designation of particular substances as controlled substances. Management of Pain and Other Conditions with Controlled Substances Part 14 nmac-16.10.14-2022-02-08.pdf
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |